BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 101889)

  • 21. A behavioral comparison of Nexus, cathinone, BDB, and MDA.
    Bronson ME; Jiang W; DeRuiter J; Clark CR
    Pharmacol Biochem Behav; 1995; 51(2-3):473-5. PubMed ID: 7667371
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of substituted-amphetamine hallucinogens using the cat limb flick model.
    Rusterholz DB; Spratt JL; Long JP; Barfknecht CF
    Commun Psychopharmacol; 1977; 1(6):589-92. PubMed ID: 608329
    [No Abstract]   [Full Text] [Related]  

  • 23. Differentiation of pressor and behavioral effects of d-amphetamine and 2,5-dimethoxy-4-methylamphetamine (STP) by cinanserin.
    Huang JT; Ho BT
    Can J Physiol Pharmacol; 1973 Dec; 51(12):976-80. PubMed ID: 4777246
    [No Abstract]   [Full Text] [Related]  

  • 24. Profiles of psychedelic drugs: 10. DOB.
    Shulgin A
    J Psychoactive Drugs; 1981; 13(1):99. PubMed ID: 7277091
    [No Abstract]   [Full Text] [Related]  

  • 25. Some effects of the hallucinogenic drug 2,5-dimethoxy-4-methylamphetamine on the metabolism of biogenic amines in the rat brain.
    Leonard BE
    Br J Pharmacol; 1972 May; 45(1):165P-166P. PubMed ID: 5041482
    [No Abstract]   [Full Text] [Related]  

  • 26. Dihydrobenzofuran analogues of hallucinogens. 3. Models of 4-substituted (2,5-dimethoxyphenyl)alkylamine derivatives with rigidified methoxy groups.
    Monte AP; Marona-Lewicka D; Parker MA; Wainscott DB; Nelson DL; Nichols DE
    J Med Chem; 1996 Jul; 39(15):2953-61. PubMed ID: 8709129
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of chirality on serotonin receptor affinity.
    Glennon RA
    Life Sci; 1979 Apr; 24(16):1487-92. PubMed ID: 470548
    [No Abstract]   [Full Text] [Related]  

  • 28. Structure and function of serotonin 5-HT2 receptors.
    Shih JC; Chen K; Gallaher TK
    NIDA Res Monogr; 1994; 146():284-97. PubMed ID: 8742804
    [No Abstract]   [Full Text] [Related]  

  • 29. Intraventricular injections of galanin counteract development of head twitches induced by the 5-HT-2 agonist 1-(2,5-dimethoxyphenyl-4-bromo)-2-aminopropane.
    Ogren SO; Fuxe K
    Acta Physiol Scand; 1989 Jun; 136(2):297-8. PubMed ID: 2476910
    [No Abstract]   [Full Text] [Related]  

  • 30. Comparison of the behavioral responses induced by phenylalkylamine hallucinogens and their tetrahydrobenzodifuran ("FLY") and benzodifuran ("DragonFLY") analogs.
    Halberstadt AL; Chatha M; Stratford A; Grill M; Brandt SD
    Neuropharmacology; 2019 Jan; 144():368-376. PubMed ID: 30385253
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Are receptor studies useful for clinical practice?
    Richelson E
    J Clin Psychiatry; 1983 Sep; 44(9 Pt 2):4-9. PubMed ID: 6313632
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Isomeric cyclopropyl ring-methylated homologues of trans-2-(2,5-dimethoxy-4-methylphenyl)cyclopropylamine, an hallucinogen analogue.
    Jacob JN; Nichols DE
    J Med Chem; 1982 May; 25(5):526-30. PubMed ID: 7086838
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stereospecific requirements for hallucinogenesis.
    Shulgin AT
    J Pharm Pharmacol; 1973 Mar; 25(3):271-2. PubMed ID: 4146335
    [No Abstract]   [Full Text] [Related]  

  • 34. The effects of 2,5-dimethoxy-4-methylamphetamine (DOM) on operant behavior: interactions with other neuroactive agents.
    Commissaris RL; Semeyn DR; Moore KE; Rech RH
    Commun Psychopharmacol; 1980; 4(5):393-404. PubMed ID: 6120791
    [No Abstract]   [Full Text] [Related]  

  • 35. A common mechanism for lysergic acid, indolealkylamine and phenethylamine hallucinogens: serotonergic medication of behavioral effects in rats.
    Sloviter RS; Drust EG; Damiano BP; Connor JD
    J Pharmacol Exp Ther; 1980 Aug; 214(2):231-8. PubMed ID: 6104720
    [No Abstract]   [Full Text] [Related]  

  • 36. Hallucinogens acting at 5-HT receptors: toward a mechanistic understanding at atomic resolution.
    Weinstein H; Zhang D; Ballesteros JA
    NIDA Res Monogr; 1994; 146():241-62. PubMed ID: 8742802
    [No Abstract]   [Full Text] [Related]  

  • 37. Recognition and activation mechanisms on the LSD/serotonin receptor: the molecular basis of structure activity relationships.
    Weinstein H; Green JP; Osman R; Edwards WD
    NIDA Res Monogr; 1978; (22):333-58. PubMed ID: 101884
    [No Abstract]   [Full Text] [Related]  

  • 38. Phenylakylamines with potential psychotherapeutic utility. 1. 2-Amino-1-(2,5-dimethoxy-4-methylphenyl)butane.
    Standridge RT; Howell HG; Gylys JA; Partyka RA; Shulgin AT
    J Med Chem; 1976 Dec; 19(12):1400-4. PubMed ID: 1003425
    [No Abstract]   [Full Text] [Related]  

  • 39. Nature of receptors involved in apomorphine responses in pigeons.
    Saxena PN; Chawla N; Johri MB; Iqbal S
    Psychopharmacology (Berl); 1977 Jun; 53(1):89-95. PubMed ID: 407618
    [No Abstract]   [Full Text] [Related]  

  • 40. Phenylalkylamines with potential psychotherapeutic utility. 2. Nuclear substituted 2-amino-1-phenylbutanes.
    Standridge RT; Howell HG; Tilson HA; Chamberlain JH; Holava HM; Gylys JA; Partyka RA; Shulgin AT
    J Med Chem; 1980 Feb; 23(2):154-62. PubMed ID: 7359529
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.